Who We Are
EMBIO Diagnostics is a rapidly growing biotech company which designs and develops innovative, portable, biosensor-based digital devices for rapid diagnostics.
Our devices find applications covering the needs of a wide range of industries including environmental, food safety, maritime and medical sectors.
EMBIO is creating the future with in-house knowhow of complex algorithm building combined with AI and machine learning.
One device, hundreds of applications
B.EL.D™ [Bio Electric Diagnostics] device combined with our proprietary algorithms and machine learning, is one of the few multi-purpose portable chemical analyzer systems in the market.
B.EL.D™ is affordable, reliable, accurate, platform ready and suitable for in-the-field use
B.EL.D™ applications are limited only by your specific industrial and scientific research needs.
airbeld with its powerful sensors and proprietary algorithm, provides real-time understanding of indoor pollutants and helps take informed decisions to sustain a healthy and comfortable environment.
It is an integrated monitoring system capable of determining IAQ as well as detecting high hazardous incidents.
EMBIO Diagnostics member of OpenAgri consortium: The EU Project Empowering Farmers with Open-Source Tools
OpenAgri, a Horizon project funded by the European Union, running from January 2024 to December 2026, aims to empower farmers with free, open-source tools that can operate even in remote locations with limited network connectivity. Led by the University of Maastricht...
PERHA Group pioneers employee wellness with our airbeld Eos technology! 🍃🏢 We're excited to reveal that PERHA Group has made a powerful commitment towards their employees' wellbeing by incorporating our trailblazing airbeld Eos technology into their offices. This...
Microsoft Azure customers worldwide now gain access to airbeld by EMBIO Diagnostics to take advantage of the scalability, reliability, and agility of Azure to drive application development and shape business strategies. NICOSIA, Cyprus — January 4, 2024 EMBIO...